Duca; Jose S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Duca; Jose S..The latest application filed is for "substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists".

Company Profile

1.14.16

Duca; Jose S. - Cranford NJ US
Duca; Jose S. - Hopkinton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anilinopiperazine derivatives and methods of use thereof Grant 9,206,142 - Shipps, Jr. , et al. December 8, 2	2015-12-08
3-heterocyclic substituted indole derivatives and methods of use thereof Grant 8,765,757 - Chan , et al. July 1, 2	2014-07-01
Indole Derivatives Useful As Ccr2 Antagonists App 20140005174 - Nair; Anilkumar G. ; et al.	2014-01-02
Substituted 3-azabicyclo[3.1.0]hexane Derivatives Useful As Ccr2 Antagonists App 20140005165 - Nair; Anilkumar G. ; et al.	2014-01-02
Substituted indole derivatives and methods of use thereof Grant 8,614,229 - Anilkumar , et al. December 24, 2	2013-12-24
4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,557,848 - Chen , et al. October 15, 2	2013-10-15
Anilinopiperazine Derivatives And Methods Of Use Thereof App 20120328691 - Shipps, JR.; Gerald W. ; et al.	2012-12-27
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Grant 8,318,735 - Shipps, Jr. , et al. November 27, 2	2012-11-27
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Grant 8,227,605 - Shipps, Jr. , et al. July 24, 2	2012-07-24
2,3-substituted indole derivatives for treating viral infections Grant 8,143,305 - Anilkumar , et al. March 27, 2	2012-03-27
Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides Grant 8,034,907 - Taremi , et al. October 11, 2	2011-10-11
3-heterocyclic Substituted Indole Derivatives And Methods Of Use Thereof App 20110165118 - Chan; Tin-Yau ; et al.	2011-07-07
Substituted Indole Derivatives And Methods Of Use Thereof App 20110104110 - Anikumar; Gopinadhan N. ; et al.	2011-05-05
2,3-substituted Indole Derivatives For Treating Viral Infections App 20110033417 - Anilkumar; Gopinadhan N. ; et al.	2011-02-10
Soluble, Stable Form Of Hdm2, Crystalline Forms Thereof And Methods Of Use Thereof App 20100136620 - Taremi; Shahriar Shane ; et al.	2010-06-03
2-aminothiazole-4-carboxylic Amides As Protein Kinase Inhibitors App 20100130465 - Shipps, JR.; Gerald W. ; et al.	2010-05-27
4,5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100098661 - Chen; Kevin X. ; et al.	2010-04-22
Pyrrolo [3, 2-a] Pyridine Derivatives For Inhibiting Ksp Kinesin Activity App 20100068181 - Paliwal; Sunil ; et al.	2010-03-18
2-aminothiazole-4-carboxylic Amides As Protein Kinase Inhibitors App 20100055090 - Shipps, JR.; Gerald W. ; et al.	2010-03-04
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof Grant 7,632,920 - Taremi , et al. December 15, 2	2009-12-15
High affinity quinoline-based kinase ligands Grant 7,511,063 - Deng , et al. March 31, 2	2009-03-31
Novel high affinity quinoline-based kinase ligands App 20080045568 - Deng; Yongqi ; et al.	2008-02-21
Compounds for inhibiting KSP kinesin activity App 20060247320 - Tagat; Jayaram R. ; et al.	2006-11-02
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof App 20050037383 - Taremi, Shahriar Shane ; et al.	2005-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.